Repletion of Ergothioneine in Patients With Kidney Failure

ConditionEsrd
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorStanford University

About this trial

Dialysis removes potentially harmful chemicals from the blood but can also remove potentially valuable chemicals. One potentially valuable chemical called ergothioneine, which comes from the diet, is low in the blood of people receiving dialysis. For this research study, the investigators hope to learn how well a daily ergothioneine supplement will replenish the levels in the blood of people with kidney failure.

Eligibility criteria

Qualifiers

kidney failure receiving hemodialysis or peritoneal dialysis

Disqualifiers

blood transfusion within 90 days

taking supplements which contain ergothioneine

Trial design

Treatments tested in this trial

  • Ergothioneine
  • Placebo

Treatment groups

28 Participants
are divided into 2 treatment groups

Sponsors and collaborators